Abstract
Introduction
Necrotising enterocolitis (NEC) is a serious inflammatory disease of the immature gastrointestinal tract, characterised by variable damage that can range from mucosal injury to necrosis and perforation [1] . Pathogenesis remains incompletely understood, but the most consistent risk factors are preterm birth and growth restriction, with the incidence inversely related to gestational age and birth weight [1] . NEC is the most common abdominal emergency in preterm infants and surgical management is required in up to 42% of cases [1] . Mortality is high, ranging from 10 to 41% [2] . Infants that survive NEC are at high risk of neurodevelopmental and growth impairment [3] .
The nutritional support of preterm infants that develop NEC is challenging, especially among those that develop short bowel syndrome [4] . Parenteral nutrition (PN) is the mainstay of management, but the optimum rate of growth and magnitude of nutrient delivery are uncertain [5] . International consensus guidelines, such as those from ESPGHAN, acknowledge the poor evidence base for recommendations [6] . However, slower growth is associated with poorer neurodevelopmental outcomes [7, 8] .
The standard anthropometric parameters, weight, height, and head circumference, provide information on the quantity of growth but not on quality of growth [9, 10] . The aim of this exploratory study was to evaluate the body composition of very preterm infants following surgically and medically managed NEC, in comparison to those that did not develop the disease, in the context of a randomised controlled trial of PN. The nutritional management after NEC in infants who do not require surgery is also challenging [4] .
Patients and Methods

Study Design
We conducted an exploratory analysis utilising data from the NEON trial [11] , a double blind multicentre randomised controlled study of PN in preterm infants <31 weeks gestational age conducted between 2010 and 2013. NEON was a 2-by-2 factorial trial comparing incremental versus immediate delivery of parenteral amino acids on non-adipose tissue (lean) mass (non-ATM), and SMOFLipid versus intralipid on intrahepatocellular lipid content [11] . The study was preregistered (ISRCTN29665319; EudraCT 2009-016731-34) and approved by the UK National Research Ethics Service and Medicines and Healthcare Products Regulatory Agency. There were no significant differences in the 2 primary outcome measures with either intervention [11] .
Nutritional Management in the NEON Trial [11] Preterm infants received 1.7 g/kg/day of amino acids on day 1, 2.1 g/kg/day on day 2, and a maximum of 2.7 g/kg/day from day 3 (incremental regimen group), or a maximum of 3.6 g/kg/day of amino acids from day 1 (immediate regimen group). PN was provided in an aqueous volume of 90 mL/kg/day on days 1 and 2, and 120 mL/kg/day from day 3. The carbohydrate intake was 8.6 g/kg/ day from day 1. Intravenous lipid was provided at 2 g/kg/day on day 1, increasing to 3 g/kg/day from day 2. Weaning of the trial PN commenced once an infant received milk volumes >60 mL/kg/day. Trial PN ceased when an infant had received and tolerated 150 mL milk/kg/day for at least 24 h. Once infants were fully established on enteral feeds, any further PN use was determined by the attending clinician. Enteral feeds were subsequently generally advanced to around 200 mL/kg/day with suckled feeds at the breast commenced at around 34 weeks postmenstrual age. Detailed nutritional intake was captured from birth until discharge from the neonatal unit on a web-based electronic case record form (In Form Integrated Trial Management system). Enteral feeding after surgically managed NEC was determined by the clinician based on the type of surgery and tolerance of milk.
Study Population
We identified infants in the NEON [11] dataset that required surgery for NEC and infants with a clinical diagnosis of NEC that were managed without surgery. For the purposes of this analysis, NEC surgery was defined as a baby with NEC who had NEC at laparotomy with histological confirmation. The diagnosis of NEC is acknowledged to be subjective [12] , therefore NEC-medical was defined as any infant who had a continuous period of being nil by mouth of at least 7 days and a diagnosis of NEC recorded in the National Neonatal Research Database (NNRD), a UK neonatal National Research Ethics Service-approved database [13] , which holds a predefined set of information extracted from the point-ofcare, clinician-entered Electronic Patient Records of all admissions to neonatal units in England, Wales, and Scotland. The reference group consisted of all other infants recruited to the NEON trial [11] .
Primary and Secondary Outcomes
The primary outcome was (lean) non-ATM. Secondary outcomes were total adipose tissue volume (ATV), adipose tissue compartments as previously defined [14] (Fig. 1) , and the ratio of the sum of the internal abdominal and deep subcutaneous abdominal adipose tissue compartments to the sum of all other adipose tissue compartments (adipose tissue ratio).
Magnetic Resonance Imaging
Whole body magnetic resonance (MR) imaging and in vivo hepatic 1 H MR spectroscopy were carried out between 37 and 44 weeks postmenstrual age as part of the NEON trial [11] . MR images were acquired on a Phillips 1.5-T machine. Preterm infants were scanned in natural postprandial sleep, without sedation in accordance with our standard protocol [14, 15] . Image analysis using SliceOmatic was undertaken independently, blind to participant identity and group allocation, by Vardis Group (London, UK; www.vardisgroup.com). MRI is the only non-invasive method to quantify the quantity and distribution of adipose tissue and correlates well with the gold standard of cadaveric dissection [16] .
Estimation of Adipose Tissue and Non-Adipose Tissue Content
Serial axial images (5 mm slice and interslice thickness) were obtained to quantify total ATV as the sum of 6 discrete depots as previously described (Fig. 1 ) [14] . We estimated non-ATM as the difference between body weight and total ATV using the formula: non-ATM = body weight (g) -(total ATV (cm 3 ) × 0.9) [11] .
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Statistical Analysis Demographic data and descriptive statistics were expressed as the frequency distribution, mean, median, standard deviation (SD), interquartile range (IQR) or confidence interval (95% CI). Weight was transformed into Z-scores using the LMS method [17] , based on sex and gestational age-specific growth charts (www. healthforallchildren.com/lmsgrowth) [18] . Multivariable linear regression was used to examine the association between the outcomes (total ATV and non-ATM) and NEC status with adjustment for the covariates sex [19] , gestational age at birth [20] , birth weight Z-score [21] , postmenstrual age at scan [22] , and length at scan to adjust for body size [23] . Estimated adjusted means and adjusted mean differences with 95% confidence intervals (CI) are reported. Data were analysed with the software Statistical Package for Social Science (SPSS version 23) and the statistical software R. A p value <0.05 was considered statistically significant.
Results
Baseline Characteristics
We included all preterm infants from the NEON trial [11] that survived to have a MR assessment at term (n = 133). Of these, 8 (6%) required surgery for NEC (NECsurgical group), 15 (11.3%) had medically managed NEC (NEC-medical group), and 110 (82.7%) had no NEC (reference group). The baseline characteristics are illustrated in Table 1 . Gestational age at birth and birth weight were lower in the NEC-surgical and NEC-medical groups than in the reference group. Birth weight, length, and head circumference Z-scores were similar across the 3 groups. At Values are n (%) or the median (interquartile range). MRI scan, body weight, length, and head circumference Z-scores were lower in the NEC-surgical group and NECmedical group in comparison to the reference group (Table 1). Infants in the NEC-surgical and NEC-medical groups received PN for a longer period, were discharged later from hospital, and underwent MR imaging at a later postmenstrual age in comparison with the reference group (Table 1) . Cumulative parenteral and enteral nutritional intakes for the 3 groups from birth to 34 weeks postmenstrual age (when infants commence direct feeds at the breast) are shown in Table 2 . The percentage of babies with blood culture-proven sepsis was 62.5% (n = 5/8) in the NEC-surgical, 53.3% (n = 8/15) in the NEC-medical, and 15.5% (n = 17/110) in the reference group. The nutritional regimens to which babies in the 3 groups were randomised to in the NEON trial [11] are shown in online supplementary Table 1 (for all online suppl. material, see www.karger.com/doi/10.1159/000485827). Values are n or the median (interquartile range). Table 3 ]. There were no significant differences in non-ATM [NEC-surgical: -46 g (-281, 189); p = 0.70; NEC-medical: -122 g (-308, 63); p = 0.20; Table 3 ]. There were no significant differences in the adipose tissue ratio in either of the 2 NEC groups compared to the reference group (Table 3) . Unadjusted values of weight at MRI scan, total ATV, ATV compartments, non-ATM, percentage ATM, and adipose tissue ratio in the NEC-surgical, NEC-medical, and reference groups are shown in Table 4 .
Discussion
We evaluated the body composition of preterm infants with surgically and medically managed NEC, in comparison to infants without NEC, using whole body MR at term. We found that total ATV was significantly lower in the NEC-surgical and NEC-medical groups, and that this difference accounted for their lower body weight in comparison to the reference group. Of note, we found no significant differences in non-ATM between the groups.
Our study was an exploratory analysis of preterm infants recruited into a randomised controlled trial of PN that was powered to detect a clinically relevant difference in non-ATM at term [11] . We acknowledge that the exploratory nature of the analysis and the small sample size generate hypotheses rather than providing conclusive mechanistic explanations for the differences observed. NEC surgery is well recognised to be associated with impairment of growth and neurodevelopment [3, 24] . Walsh et al. [24] reported a significant correlation between the severity of NEC and growth delay in preterm infants at a postmenstrual age of 20 months. Hintz et al. [3] showed that surgically but not medically managed NEC is associated with significant growth delay at 12 and 18 months postmenstrual age in comparison to infants without NEC. Our study provides a novel insight into quantifying adipose tissue content and non-ATM in relation to NEC. All adipose tissue compartments were lower in the NEC groups indicating that, although total ATV was reduced, there was no difference in the distribution of adipose tissue. The reduction in total ATV in comparison to infants without the disease was more marked in the NEC-surgical group, in whom the disease would have been more severe, than in the NEC-medical group. The greater reduction in total ATV in the NEC-surgical group might indicate inadequate nutritional delivery, enteral intolerance, and malabsorption, or non-nutritional growth compromise as a consequence of the inflammatory response of the acute disease, or repeated episodes of PNrelated sepsis [3, 4] . It is well known that sepsis increases 3 11 (7) 15 (6) 17 (9) Total internal adipose tissue, cm 3 63 (36) 97 (54) 76 (34) Internal abdominal adipose tissue, cm 3 15 (9) 23 (14) 17 ( energy expenditure and influences body weight and composition [25] . In our study, culture-proven sepsis was substantially more frequent in preterm infants in the NEC-surgical (62.5%) and NEC-medical groups (53.3%) than in the reference group (15.5%). These data suggest that infants in the NEC-groups had higher energy expenditure than infants in the reference group, and this factor might lead to a reduction in ATV. Furthermore, we consider non-nutritional growth compromise to be unlikely for 3 reasons: first we identified no reduction in non-ATM which would have been expected in this situation; second, non-nutritional growth compromise is often accompanied by an increase in internal abdominal adiposity [20] , but the distribution of adipose tissue was not affected, and third, after acute weight loss, such as might be anticipated during acute NEC, weight regain disproportionately reflects the deposition of adipose tissue over lean body mass (the catch-up fat phenomenon) [26, 27] . This phenomenon was not observed in our study, suggesting that nutritional management was sufficient to prevent loss of body tissue during the acute illness but insufficient to support the deposition of adipose tissue during the period after recovery from NEC [27] . As catchup growth appears to adversely impact upon later metabolic health and longevity in every species studied including man [28] , whether this may ultimately be beneficial to the life-long well-being of the very preterm infant is an intriguing possibility.
Our study also raises hypotheses in relation to preterm infants without NEC, for whom we had a substantial large sample size. The mean value for adjusted total ATV in this reference group (719 cm 3 ) is very similar to values we identified in previous research in preterm infants at term (577 and 711 cm 3 ) [20, 29] and healthy term infants at term (661 and 700 cm 3 ) [20, 29] . Conversely, the mean adjusted non-ATM in the reference group (2,425 g) was slightly greater than in preterm infants at term in our previous research (2,179 and 2,370 g) [20, 29] , and less than in healthy term infants (2,875 and 2,680 g) [20, 29] . In a systematic review and meta-analysis of studies of body composition, Johnson et al. [30] identified a significantly lower non-ATM in preterm infants at term, in comparison with full-term infants. Taken together, these data firstly provide corroborative evidence that in comparison with healthy full-term infants, very preterm infants accumulate a deficit in non-ATM by term, although total ATV is preserved; secondly, there is evidence from our current and previous research that the deficit in non-ATM is becoming less marked with time, suggesting that preterm nutritional support is improving.
Infants in the NEON trial [11] received a standardised nutritional management regimen based on current expert consensus and theoretical considerations [6] , rather than evidence of benefit to functional outcomes. Our data are reassuring in providing indirect evidence that the NEON regimen [11] , during both the PN and post-PN periods up to term, was adequate to preserve non-ATM, relative to preterm infants without NEC, despite the not inconsiderable inflammatory and metabolic stresses of NEC, surgery, and postoperative nutritional rehabilitation, while avoiding the excessive adiposity of catch-up growth. However, this nutritional regimen appears inadequate to achieve growth and body composition equal to that of the full-term infant. Therefore, an important ongoing uncertainty in preterm practice is whether nutritional practices that target the body composition of the full-term infant result in a benefit to preterm neurodevelopment without compromise to metabolic health and longevity.
Conclusion
The lower weight at term in preterm infants following surgically and medically managed NEC, in comparison to preterm infants who did not develop the disease, was secondary to a reduction in ATV. This suggests that the nutritional regimen received was adequate to preserve non-ATM, but not to support normal third trimester adipose tissue deposition in preterm infants.
